Accordingly, in a different subtype of bladder cancer, muscle-invasive bladder cancer, recurrent mutations in RXRα lead to an imbalance of the PPARγ/RXRα heterodimer, and focal amplification of PPARγ. The gene discussed is RXRA; the disease is urinary bladder cancer.